What Makes a Competent Psychedelic Therapist Beyond Degrees

Meet Matthew Johnson, PhD, psychedelic researcher, experimental psychologist, senior investigator, and professor at Johns Hopkins University.

#Psychedelics #PsychedelicResearch #PatientCenteredCare

What Placebo Can Cost Participants in Prolonged Crossover Trials

Meet Kathy Neustadt, a clinical trial participant who received placebo in an MDMA-assisted therapy research for PTSD.

#PsychedelicTherapy #PsychedelicResearch #PatientSafety #ClinicalTrials #placeboeffect

Upcoming workshop: Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC (19:00 Central Europe)

Discover how to leverage lived experience as quality and safety infrastructure in psychedelic care.

#PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials

Collective Continuance: Indigenous Knowledge Fellowship - UC Berkeley Center for the Science of Psychedelics The Collective Continuance: Indigenous Knowledge Fellowship supports early-career scholars who are navigating complex questions at the intersection of Indigenous knowledge and psychedelic research.

🌿 Applications are open for the Collective Continuance Fellowship!

We’re supporting PhD students bridging Indigenous knowledge & psychedelic research through ethical scholarship.

Apply or share: psychedelics.berkeley.edu/collective-continuance-fellowship
#IndigenousStudies #PsychedelicResearch

When Lived Experience Is Shared on Stage, Safety Matters

Meet Joost Breeksema, PhD, a qualitative researcher in psychedelic trials and Executive Director of the OPEN Foundation in the Netherlands, which organizes the ICPR conference (June 4-6, 2026).

#Psychedelics #PsychedelicResearch

RobinReach

WARNING: Psilocybin Is Killing Your Ego (The Science). What does the research actually show about ego dissolution and the brain? Watch: https://youtu.be/A8MurmqZUWo 🧠🔬
Educational content only not medical advice. #Neuroscience #PsychedelicResearch #MentalHealth #Science

In psychedelic care, safety is often about the dosing day.

If we want a more honest standard, safety cannot mean only “nothing visibly went wrong during treatment.” It has to include what happens after, when real life resumes.

#PsychedelicResearch #PatientSafety #ClinicalTrials #Psychedelics

Joining this workshop? Lived Experience as Quality and Safety Infrastructure in Psychedelic Care

🗓 Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC

If you’re a clinician/therapist, researcher, QA, program lead, or study staff, this is for you.

#PsychedelicTherapy #PsychedelicResearch #Psychedelics

All About DMTx (extended-state DMT) | Hayley and Kevin of Dream Mind Labs - ATTMind Podcast 206 Featuring Dream Mind Labs, this episode is going to be a deep dive into extended-state dimethyltryptamine, otherwise known as DMTx.

All About DMTx (extended-state #DMT) | Hayley and Kevin of Dream Mind Labs - ATTMind Podcast 206

www.jameswjesso.com/all-about-dm...

#psychedelics #psychedelicresearch

The New Psychedelic Patrons: How Philanthropy Is Powering a Once-Taboo Medical Field Private donations have played a key role in propelling research that was once on the fringe toward the medical mainstream.

Private donations have played a key role in propelling research that was once on the fringe toward the medical mainstream.

Katherine Don Reports: tinyurl.com/bd5e24bc

#PsychedelicResearch #MentalHealth #HealthPhilanthropy #ScientificResearch #DrugPolicy #PTSDTreatment #AddictionRecovery

Eligibility criteria are necessary. They help ensure safety, consistency, and rigor in research.

But they also simplify.

People don’t arrive as clean variables. They arrive with overlapping histories, contexts, and contradictions.

#PsychedelicResearch #PatientCenteredCare #Psychedelics

Why Individual Treatment May Not Be Enough in Psychedelic Care

Meet Chris Stauffer, MD, psychiatrist, addiction medicine specialist, and investigator of group MDMA therapy for veterans with PTSD.

#PsychedelicTherapy #PsychedelicResearch #PeerSupport #LivedExperience #MDMAtherapy

What Being Taken Off the Clinical Trial Really Felt Like

Meet Kerrilee Barrett, a mental health practitioner who participated in a clinical trial involving a psychoactive substance for PTSD.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #Psychedelics

Ibogaine Care and Why Lived Experience Matters

Meet Jonathan Dickinson, a psychologist, renowned Ibogaine expert, published researcher, and CEO & co-founder at Ambio Life Sciences.

#PsychedelicTherapy #PsychedelicResearch #LivedExperience #Ibogaine #Iboga #Psychedelics

Psychedelic clinical trials often focus on symptom reduction. That matters, but it is not the full story.

A participant can look improved on a clinical scale while still struggling with stability, relationships, meaning-making, or life after the protocol ends.

#PsychedelicResearch #ClinicalTrials

How Psilocybin Therapy Changed the Way I Process Emotions

Meet Daryna Skybina, MPS who participated in a clinical trial studying psilocybin-assisted therapy for people with advanced cancer.

#PsychedelicTherapy #PsychedelicResearch #LivedExperience #CancerResearch #PatientVoices #Psychedelics

King County committee adopts amendment backing deprioritization of entheogen prosecutions, sends motion to full council The Health, Housing and Human Services Committee adopted a striking amendment and recommended a due pass on a motion urging deprioritization of criminal enforcement for certain personal entheogen uses, while clarifying the measure does not restrain law enforcement from addressing harmful or illegal conduct.

King County is taking a bold step towards the future of mental health by supporting the responsible use of entheogens for therapeutic purposes!

Learn more here

#KingCounty #WA #CriminalJusticeReform #CitizenPortal #HealthPolicy #KingCountyEntheogens #PsychedelicResearch

Safety in psychedelic care cannot rely only on protocols, clinical training, or symptom scores.

The people who go through these treatments often see risks, challenges, and gaps that formal systems miss.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #Psychedelics

Psychedelic clinical trials measure important outcomes.

But the people who go through these experiences often see dimensions of healing and challenge that standard frameworks miss.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience

Psilocybin Therapy for Depression Can Be Both Healing and Destabilizing

Meet Heather Joy, a clinical trial participant in an open-label psilocybin-assisted therapy study for treatment-resistant depression.

#PsychedelicTherapy #PsychedelicResearch #Psilocybin #Psychedelics

Destigmatization, Legalization, and Why Clear Rules Protect Patients

Meet Janina Kowalski, MD, a psychiatrist who underwent ketamine, MDMA, LSD, and psilocybin in experiential therapist training.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #PsychedelicScience

They served us. Now we serve them.
Veterans and first responders deserve every tool available for mental health— including safe, research-backed psychedelic therapy. It’s time to move from stigma to solutions. 🇺🇸

#Veterans #FirstResponders #MentalHealth #PsychedelicResearch #PTSD #EndTheStigma

Beyond Lip Service: Meaningful Inclusion of Lived Experience

Meet Simon Amar, MD, a psychiatrist and investigator for MDMA for PTSD and psilocybin for anxiety clinical trials

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

Committee endorses time-limited veterans PTSD research trial with legislative guardrails (HB 390) The committee favorably recommended first substitute HB 390 to authorize a tightly scoped, time-limited clinical research trial on psychedelic-assisted therapy for treatment-resistant PTSD among veterans, with oversight by FDA, DEA and an institutional review board; veterans and researchers testified in strong support.

A groundbreaking bill has been endorsed to explore psychedelic-assisted therapy for veterans suffering from treatment-resistant PTSD, promising hope for those who have struggled to find healing.

Learn more here

#UT #PTSDTreatment #CitizenPortal #MentalHealth #PsychedelicResearch

MDMA-Assisted Therapy Trial: Safety, Trust, and Returning to Work

Meet Sehrish Sayani, who participated in a Phase 3 MDMA-assisted therapy clinical trial for PTSD.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

William James helped lay the foundations of modern psychology.

And yet his insight still challenges us:

What we choose to attend to shapes what we call knowledge.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

House approves clinical research measure to study psychedelic-assisted PTSD treatments for veterans The House passed first substitute HB 390 to establish a tightly controlled clinical research program studying psychedelic-assisted treatments for treatment-resistant PTSD among veterans, to be conducted at Huntsman Mental Health Institute under FDA/DEA and IRB protocols.

Utah is taking a groundbreaking step by approving a bill to explore psychedelic-assisted treatments for veterans battling treatment-resistant PTSD, aiming to combat the urgent crisis of veteran suicides.

Click to read more!

#UT #PTSDTreatment #CitizenPortal #MentalHealth #PsychedelicResearch

The Importance of Sharing Nuanced and Difficult Psychedelic Experiences

Meet Will Barone, Psy.D, a clinical psychologist and qualitative researcher in studies with MDMA, psilocybin, & ketamine

#PsychedelicTherapy #PsychedelicResearch #LivedExperience #PsychedelicScience

Inside Group Ketamine-Assisted Therapy: A Firsthand Experience

Meet Jana Sladkova, PhD, who participated in a group ketamine-assisted therapy program for depression.

#PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

The psychedelic field is producing more data than ever. More trials. More publications. More outcome measures.

Lived experience isn’t missing because it lacks insight. It’s missing because we haven’t structurally prioritized listening.

#PsychedelicTherapy #PsychedelicResearch #Psychedelics